Company: RGNT
Filing Date: 2025-02-12
Form Type: DRS/A
Source: 0001213900-25-012299
Chunk: 237

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-02-12
Form: DRS/A
Chunk 237
---
 offering material relating to the securities have been or will be filed with or approved by any Swiss regulatory authority.
In particular, this document will not be filed with, and the offer of securities will not be supervised by, the Swiss Financial Market
Supervisory Authority (FINMA).

This document is personal
to the recipient only and not for general circulation in Switzerland.

Hong Kong

Neither the information in
this document nor any other document relating to the offer has been delivered for registration to the Registrar of Companies in Hong Kong,
and its contents have not been reviewed or approved by any regulatory authority in Hong Kong, nor have we been authorized by the Securities
and Futures Commission in Hong Kong. This document does not constitute an offer or invitation to the public in Hong Kong to acquire securities.
Accordingly, unless permitted by the securities laws of Hong Kong, no person may issue or have in its possession for the purpose of issue,
this document or any advertisement, invitation or document relating to the securities, whether in Hong Kong or elsewhere, which is directed
at, or the contents of which are likely to be accessed or read by, the public in Hong Kong other than in relation to securities which
are intended to be disposed of only to persons outside Hong Kong or only to “professional investors” (as such term is defined
in the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong), or SFO, and the subsidiary legislation made thereunder) or
in circumstances which do not result in this document being a “prospectus” as defined in the Companies (Winding Up and Miscellaneous
Provisions) Ordinance of Hong Kong (Cap. 32 of the Laws of Hong Kong), or the CO, or which do not constitute an offer or an invitation
to the public for the purposes of the SFO or the CO. The offer of the securities is personal to the person to whom this document has been
delivered by or on behalf of our company, and a subscription for securities will only be accepted from such person. No person to whom
a copy of this document is issued may issue, circulate or distribute this document in Hong Kong or make or give a copy of this document
to any other person. You are advised to exercise caution in relation to the offer. If you are in any doubt about any of the contents of
this document, you should obtain independent professional advice. No document may be distributed, published or reproduced (in whole or
in part), disclosed by or to any other